Raymond James Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $1.79M | Sell |
21,343
-45
| -0.2% | -$3.77K | 0.04% | 346 |
|
2024
Q2 | $1.65M | Buy |
21,388
+4,324
| +25% | +$333K | 0.04% | 351 |
|
2024
Q1 | $1.17M | Buy |
17,064
+96
| +0.6% | +$6.58K | 0.03% | 427 |
|
2023
Q4 | $981K | Buy |
16,968
+1,187
| +8% | +$68.6K | 0.03% | 463 |
|
2023
Q3 | $833K | Buy |
15,781
+2,048
| +15% | +$108K | 0.02% | 468 |
|
2023
Q2 | $743K | Buy |
13,733
+2,244
| +20% | +$121K | 0.02% | 508 |
|
2023
Q1 | $575K | Buy |
11,489
+349
| +3% | +$17.5K | 0.02% | 580 |
|
2022
Q4 | $516K | Sell |
11,140
-752
| -6% | -$34.8K | 0.02% | 588 |
|
2022
Q3 | $461K | Sell |
11,892
-2,507
| -17% | -$97.2K | 0.02% | 605 |
|
2022
Q2 | $536K | Buy |
14,399
+293
| +2% | +$10.9K | 0.02% | 569 |
|
2022
Q1 | $625K | Sell |
14,106
-4,286
| -23% | -$190K | 0.02% | 552 |
|
2021
Q4 | $781K | Sell |
18,392
-1,628
| -8% | -$69.1K | 0.02% | 495 |
|
2021
Q3 | $868K | Buy |
20,020
+10
| +0% | +$434 | 0.03% | 443 |
|
2021
Q2 | $856K | Buy |
20,010
+4,400
| +28% | +$188K | 0.03% | 439 |
|
2021
Q1 | $603K | Buy |
15,610
+2,997
| +24% | +$116K | 0.02% | 522 |
|
2020
Q4 | $453K | Buy |
12,613
+969
| +8% | +$34.8K | 0.02% | 582 |
|
2020
Q3 | $445K | Sell |
11,644
-106
| -0.9% | -$4.05K | 0.02% | 528 |
|
2020
Q2 | $412K | Buy |
11,750
+310
| +3% | +$10.9K | 0.02% | 530 |
|
2020
Q1 | $373K | Sell |
11,440
-292
| -2% | -$9.52K | 0.02% | 478 |
|
2019
Q4 | $530K | Buy |
11,732
+1,415
| +14% | +$63.9K | 0.03% | 447 |
|
2019
Q3 | $420K | Buy |
10,317
+3,624
| +54% | +$148K | 0.02% | 517 |
|
2019
Q2 | $287K | Buy |
6,693
+363
| +6% | +$15.6K | 0.02% | 642 |
|
2019
Q1 | $243K | Sell |
6,330
-840
| -12% | -$32.2K | 0.01% | 692 |
|
2018
Q4 | $253K | Buy |
7,170
+866
| +14% | +$30.6K | 0.02% | 626 |
|
2018
Q3 | $243K | Buy |
+6,304
| New | +$243K | 0.01% | 725 |
|